📄 synthetic biology

Reprogramming a Protein Ligase for Genetic Code Expansion

By grafting the anticodon-binding domain of lysyl-tRNA synthetase onto the protein ligase EpmA, researchers engineered a chimeric enzyme (chEpmA) that successfully reprograms a protein ligase into a versatile aminoacyl-tRNA synthetase capable of charging tRNAs with diverse non-canonical substrates, including {beta}-amino acids and various post-translational modifications, to expand the genetic code.

Original authors: Gallo, G., Sieber, A., Hellwig, M., Fuerst, M. J. L. J., Lassak, J. M.

Published 2026-07-08

📖 3 min read☕ Coffee break read

CC BY 4.0

Original authors: Gallo, G., Sieber, A., Hellwig, M., Fuerst, M. J. L. J., Lassak, J. M.

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ⚕️ This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer

Imagine the cell's protein factory, the ribosome, as a master chef who can only cook with a specific set of 22 ingredients (amino acids). For a long time, scientists knew this chef had the potential to use weird, modified ingredients (like beta-amino acids), but the factory's "ingredient manager" (an enzyme called aminoacyl-tRNA synthetase) was too picky. It only accepted the standard 22, rejecting anything with a different shape or backbone.

The researchers in this paper decided to "reverse engineer" a different kind of factory worker to solve this problem.

The Original Worker: The Specialized Loader
They started with a natural enzyme from bacteria called EpmA. Think of EpmA as a specialized loader that was originally designed to grab a specific, unusual ingredient called (R)-beta-lysine and stick it onto a protein. Over time, nature evolved this loader to drop its "delivery truck" (the part that grabs the tRNA) because it didn't need it anymore; it just recognized the final protein target directly.

The Experiment: Building a Hybrid
The scientists took this specialized loader (EpmA) and performed a molecular "grafting" surgery. They attached the "delivery truck" from a standard ingredient manager (a lysine loader called LysRS) onto the EpmA body.

The result was a brand-new hybrid machine called chEpmA. This is a historic first: they successfully turned a protein loader into a functional ingredient manager (an aminoacyl-tRNA synthetase).

What the Hybrid Can Do
This new machine, chEpmA, is incredibly versatile:

It handles the weird stuff: It can efficiently grab that unusual, modified ingredient (beta-lysine) and load it onto the delivery trucks (tRNAs) so the ribosome can use it.
It can be tweaked for more: By making just one tiny change (a single substitution) to the machine, they unlocked its ability to handle standard-shaped ingredients too.

The Result: A New Menu of Proteins
With this new machine, the cell can now build proteins with a much wider variety of "toppings" that were previously impossible to add via genetic code expansion. The paper specifically lists these new capabilities:

Acylated lysines: Like adding a succinyl group to lysine (Ksucc).
Bulky modifications: Like attaching biocytin (a large molecule).
Advanced Glycation End Products (AGEs): Such as Nε-carboxymethyl-(S)-lysine (CML).

The Big Picture
The paper concludes that this work provides a "structural blueprint." It shows scientists exactly how to reprogram these molecular machines to handle non-standard ingredients. The immediate goal mentioned is to use this to build protease-resistant peptidomimetics (protein-like structures that don't break down easily) and next-generation therapeutics. Essentially, they built a new tool that allows the cell to cook with a much broader, more durable, and more complex set of ingredients than ever before.

Technical Summary: Reprogramming a Protein Ligase for Genetic Code Expansion

The Problem
The natural ribosomal machinery is restricted to the polymerization of 22 canonical amino acids, limiting the structural diversity of genetically encoded proteins. While the translation apparatus possesses a latent capacity to incorporate backbone-modified substrates, such as $\beta$ -amino acids, this potential is currently constrained by the intrinsic $\alpha$ -selectivity of native aminoacyl-tRNA synthetases (aaRS). These enzymes are evolutionarily tuned to recognize $\alpha$ -amino acids, preventing the efficient charging of tRNAs with non-canonical, backbone-modified analogs required for expanding the genetic code.

Methodology
To overcome these limitations, the authors employed a "reverse engineering" strategy targeting the Escherichia coli protein ligase EpmA. Naturally, EpmA activates the non-canonical (R)- $\beta$ -lysine but has evolved to discard its tRNA-binding domain, relying instead on direct protein recognition. The researchers constructed a chimeric enzyme, termed chEpmA, by grafting the anticodon-binding domain of the canonical lysyl-tRNA synthetase (LysRS) onto the EpmA scaffold. This design aimed to repurpose the ligase's ability to recognize $\beta$ -amino acids while restoring the necessary interface for tRNA interaction.

Key Contributions and Results
The study reports the first successful reprogramming of a protein ligase into a functional aminoacyl-tRNA synthetase. The resulting chEpmA enzyme functions as a versatile dual-specificity platform with the following demonstrated capabilities:

Efficient Charging: chEpmA successfully charges tRNAs with the non-canonical backbone (R)- $\beta$ -lysine.
Scaffold Flexibility: A single substitution within the chEpmA scaffold unlocks the enzyme's capacity to process $\alpha$ -substrates, significantly broadening its substrate scope.
Expanded Substrate Repertoire: The engineered system enables the incorporation of a wide spectrum of post-translational modifications previously inaccessible to genetic code expansion. Specific examples demonstrated include:
- Acylated lysines, such as N $\varepsilon$ -succinyl-(S)-lysine (Ksucc).
- Bulky modifications, such as biocytin.
- Advanced glycation end products (AGEs), such as N $\varepsilon$ -carboxymethyl-(S)-lysine (CML).

Significance
The paper establishes a structural blueprint for mobilizing non-canonical substrates by repurposing existing protein ligases. By demonstrating that a protein ligase can be converted into an aaRS, the work provides a novel pathway for the biosynthesis of protease-resistant peptidomimetics and the development of next-generation therapeutics. This approach effectively bypasses the natural $\alpha$ -selectivity barrier, offering a new mechanism to expand the chemical diversity of the genetic code.

Technical Summary: Reprogramming a Protein Ligase for Genetic Code Expansion

More like this